Letter to the Editor: Central nervous system relapse rate and dose intensification in poor risk metastatic germ cell tumours-A comment on: 'Patterns of relapse in poor prognosis germ cell tumours in the GETUG-13 trial: Implications for the assessment of brain metastases.' by Loriot and colleagues

Eur J Cancer. 2018 May:95:102-103. doi: 10.1016/j.ejca.2018.01.116. Epub 2018 Mar 31.

¹ Department of Medical Oncology, St Bartholomew's Hospital, London, UK; Division of Cancer, University College London Hospital, London, UK.
² Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
³ Department of Medical Oncology, St Bartholomew's Hospital, London, UK. Electronic address: [email protected].

No abstract available

Publication types